ARYL-HYDROCARBON HYDROXYLASE IN LYMPHOCYTES AND LUNG-TISSUE FROM LUNG-CANCER PATIENTS AND CONTROLS

被引:56
作者
KARKI, NT
POKELA, R
NUUTINEN, L
PELKONEN, O
机构
[1] UNIV OULU,DEPT SURG,SF-90220 OULU,FINLAND
[2] UNIV OULU,DEPT ANAESTHESIOL,SF-90220 OULU,FINLAND
关键词
D O I
10.1002/ijc.2910390505
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:565 / 570
页数:6
相关论文
共 40 条
[1]   METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].
AYESH, R ;
IDLE, JR ;
RITCHIE, JC ;
CROTHERS, MJ ;
HETZEL, MR .
NATURE, 1984, 312 (5990) :169-170
[2]   HUMAN CYTOCHROMES-P-450 [J].
BOOBIS, AR ;
DAVIES, DS .
XENOBIOTICA, 1984, 14 (1-2) :151-185
[3]  
BOYUM A, 1968, SCAND J CLIN LAB S97, V21, P1
[4]  
BURKE MD, 1978, DRUG METAB DISPOS, V5, P1
[5]  
COCHIN J, 1959, J PHARMACOL EXP THER, V125, P105
[6]   METABOLIC-ACTIVATION AND DEACTIVATION OF MUTAGENS BY PREPARATIONS OF HUMAN-LUNG PARENCHYMA AND BRONCHIAL TREE [J].
DEFLORA, S ;
BENNICELLI, C ;
ZANACCHI, P ;
CAMOIRANO, A ;
PETRUZZELLI, S ;
GIUNTINI, C .
MUTATION RESEARCH, 1984, 139 (01) :9-14
[7]  
EMERY AEH, 1978, LANCET, V1, P470
[9]  
GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596
[10]  
GURTOO HL, 1975, CANCER RES, V35, P1235